| Authors: |
Chevigné A; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Legler DF; Institute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen, Switzerland; Faculty of Biology, University of Konstanz, Konstanz, Germany; Theodor Kocher Institute, University of Bern, Bern, Switzerland., Rot A; Centre for Microvascular Research, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany., Sozzani S; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Institute Pasteur-Italia, Rome, Italy., Szpakowska M; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Thelen M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. Electronic address: marcus.thelen@irb.usi.ch. |
